ConductScience.org, home

Paper4748282

Letter: Creatinine clearance: bedside estimate.

Jelliffe RW. Ann Intern Med, 1973. Cited by 450 papers, by iCite.

Cite this record

ConductScience Library. Letter: Creatinine clearance: bedside estimate. Papers, record 4748282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4748282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Letter: Creatinine clearance: bedside estimate.
PubMed
Journal
Ann Intern Med
PubMed
Year
1973
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
450
iCite
Relative citation ratio, by iCite
15.9
iCite
Revised in PubMed
2019-06-19
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jelliffe RWR W

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CreatinineMajor topic
Kidney Function TestsMajor topic
Mathematics

Cited by88

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 450 citations.

PMIDTitleJournalYearIn PapersSource
42059789A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel β-lactamase inhibitor nacubactam.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42059789PubMed
41726823Prevalence and prediction of augmented renal clearance in the neurocritical care population.J Neurocritical Care2022https://conductscience.org/library/papers/41726823PubMed
38166710Enhanced renal clearance impacts levetiracetam concentrations in patients with traumatic brain injury with and without augmented renal clearance.BMC Neurol2024https://conductscience.org/library/papers/38166710PubMed
37229879Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.Gynecol Oncol2023https://conductscience.org/library/papers/37229879PubMed
36706748Use of Race in Kidney Function Estimation: Lessons Learned and the Path Toward Health Justice.Annu Rev Med2023https://conductscience.org/library/papers/36706748PubMed
35736781Kidney Function Assessment in African American Patients: A Narrative Review for Pharmacists.Pharmacy (Basel)2022https://conductscience.org/library/papers/35736781PubMed
35372903GFR Measurement and Chemotherapy Dosing in Patients with Kidney Disease and Cancer.Kidney3602020https://conductscience.org/library/papers/35372903PubMed
35227967Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.ESMO Open2022https://conductscience.org/library/papers/35227967PubMed
34055406The Performance of Equations That Estimate Glomerular Filtration Rate against Measured Urinary Creatinine Clearance in Critically Ill Patients.Crit Care Res Pract2021https://conductscience.org/library/papers/34055406PubMed
33811332Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System.J Clin Pharmacol2021https://conductscience.org/library/papers/33811332PubMed
33672057Evaluation of Current Amikacin Dosing Recommendations and Development of an Interactive Nomogram: The Role of Albumin.Pharmaceutics2021https://conductscience.org/library/papers/33672057PubMed
33523498Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Kidney Function.Clin Pharmacol Ther2021https://conductscience.org/library/papers/33523498PubMed
31791688
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet2019https://conductscience.org/library/papers/31791688PubMed
31750418Multicenter Validation of the CamGFR Model for Estimated Glomerular Filtration Rate.JNCI Cancer Spectr2019https://conductscience.org/library/papers/31750418PubMed
31462686Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosing.Bone Marrow Transplant2020https://conductscience.org/library/papers/31462686PubMed
31452508Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy.Dtsch Arztebl Int2019https://conductscience.org/library/papers/31452508PubMed
31244657Optimizing Vancomycin Dosing in Chronic Kidney Disease by Deriving and Implementing a Web-Based Tool Using a Population Pharmacokinetics Analysis.Front Pharmacol2019https://conductscience.org/library/papers/31244657PubMed
30518813Estimated GFR: time for a critical appraisal.Nat Rev Nephrol2019https://conductscience.org/library/papers/30518813PubMed
28913589Estimating renal function in old people: an in-depth review.Int Urol Nephrol2017https://conductscience.org/library/papers/28913589PubMed
28856465Guidelines for treatment of renal injury during cancer chemotherapy 2016.Clin Exp Nephrol2018https://conductscience.org/library/papers/28856465PubMed

See all 88 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4748282

GET https://conductscience.org/api/papers/v1/4748282/cited_by?page=2